Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Human Molecular Genetics|September 13, 2015
FGFR2 mutation in 46,XY sex reversal with craniosynostosisStefan Bagheri-Fam, Makoto Ono, Li Li, et al.
Cancers|January 11, 2022
BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCLGavin D Garland, Stephen P Ducray, Leila Jahangiri, et al.
Pancreas|October 18, 2016
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway ApproachJames J Farrell, Jennifer Moughan, Jonathan L Wong, et al.
British Journal of Haematology|November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAnjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Journal of Cellular Physiology|January 19, 2010
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancerDaniele Santini, Bruno Vincenzi, Maria Elisabetta Fratto, et al.
Current Cancer Drug Targets|June 29, 2010
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)Daniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
Ebiomedicine|September 30, 2016
PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid CancerAna Lopez-Campistrous, Esther Ekpe Adewuyi, Matthew G K Benesch, et al.
Pageof 21